Galectin Therapeutics Inc. (NASDAQ:GALT)

CAPS Rating: 1 out of 5

A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.

GALT News and Commentary

  • GALTFebruary 26, 2014 Blog at The Motley Fool

Caps

How do you think GALT will perform against the market?

Add Stock to CAPS Watchlist

All Players

55 Outperform
61 Underperform
 

All-Star Players

8 Outperform
42 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top GALT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

superstar2 (99.43)
Submitted September 30, 2016

This baby is locked and loaded! Sell Off, way, way, overdone! Take advantage!

allstar31 (99.92)
Submitted September 12, 2014

Stock Promoter Pump and dump that uses Redchip.com to fool retail investors into buying. The company was formerly bankrupt and is a con job. Don't buy.

GALT VS S&P 500 (SPY)

Fools bullish on GALT are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about GALT.

Recs

0
Member Avatar SmartAce (99.97) Submitted: 6/20/2018 1:56:01 PM : Underperform Start Price: $7.99 GALT Score: +3.33

Annoying how when you go to the orchestra, there's always that one wasted dude up front swaying and waving his arms around the whole time.

Recs

0
Member Avatar ChiefPaw (42.73) Submitted: 5/16/2018 3:51:04 AM : Underperform Start Price: $4.13 GALT Score: -84.39

Fall like a rock

Recs

1
Member Avatar superstar2 (99.43) Submitted: 9/30/2016 11:29:27 AM : Outperform Start Price: $1.31 GALT Score: +460.73

This baby is locked and loaded! Sell Off, way, way, overdone! Take advantage!

Leaderboard

Find the members with the highest scoring picks in GALT.

Score Leader

farhangp

farhangp (< 20) Score: +1,191.86

The Score Leader is the player with the highest score across all their picks in GALT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
farhangp < 20 11/7/2016 Outperform 5Y $0.60 +1,169.87% +29.52% +1,140.35 0 Comment
dtotino < 20 10/26/2016 Outperform 3Y $0.80 +864.17% +28.33% +835.84 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. hayrettin 70.99 11/10/2016 Outperform 5Y $0.83 +824.21% +26.70% +797.51 0 Comment
dragonLZ 91.29 11/21/2016 Outperform 5Y $0.96 +698.96% +25.35% +673.60 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. superstar2 99.43 9/28/2016 Outperform 5Y $1.31 +487.74% +27.01% +460.73 1 Comment
Under5 52.60 2/15/2017 Outperform 5Y $1.66 +362.05% +17.69% +344.36 0 Comment
portefeuille 98.91 12/19/2017 Outperform 5Y $2.01 +281.59% +2.33% +279.26 0 Comment
portefeuille2 99.65 9/22/2016 Outperform 5Y $2.73 +180.95% +26.49% +154.46 0 Comment
portefeuille3 98.40 5/1/2015 Outperform 5Y $2.90 +164.48% +31.05% +133.43 0 Comment
spirts < 20 12/24/2014 Outperform 5Y $3.04 +152.30% +32.07% +120.23 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
trackascendiantc < 20 10/7/2013 Outperform NS $11.50 -33.30% +64.10% -97.41 0 Comment
trackaegiscorp 48.50 7/26/2012 Outperform NS $2.80 +173.93% +102.18% +71.75 0 Comment
trackglobalhunte < 20 12/19/2011 Outperform NS $5.02 +52.91% +125.09% -72.18 0 Comment

Featured Broker Partners


Advertisement